{"id":67278,"date":"2026-06-04T09:36:03","date_gmt":"2026-06-04T04:06:03","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=67278"},"modified":"2026-06-04T09:36:05","modified_gmt":"2026-06-04T04:06:05","slug":"contrast-associated-acute-kidney-injury","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/","title":{"rendered":"Contrast-Associated Acute Kidney Injury"},"content":{"rendered":"<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/7HO3ju26V8s?si=_oFU2bWCjC68-i0I\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n\n<p class=\"wp-block-paragraph\">Contrast-Induced Acute Kidney Injury (CI-AKI) is being increasingly referred to as <a href=\"https:\/\/kdigo.org\/wp-content\/uploads\/2026\/03\/KDIGO-2026-AKI-AKD-Guideline-Public-Review-Draft-March-2026.pdf\" type=\"link\" id=\"https:\/\/kdigo.org\/wp-content\/uploads\/2026\/03\/KDIGO-2026-AKI-AKD-Guideline-Public-Review-Draft-March-2026.pdf\">Contrast-Associated Acute Kidney Injury<\/a> (CA-AKI). That is because post-contrast AKI may have causes other than contrast exposure. AKI is classically defined by the KDIGO (<a href=\"https:\/\/kdigo.org\/\" type=\"link\" id=\"https:\/\/kdigo.org\/\">Kidney Disease: Improving Global Outcomes<\/a>) <a href=\"https:\/\/kdigo.org\/wp-content\/uploads\/2016\/10\/KDIGO-2012-AKI-Guideline-English.pdf\" type=\"link\" id=\"https:\/\/kdigo.org\/wp-content\/uploads\/2016\/10\/KDIGO-2012-AKI-Guideline-English.pdf\">2012 criteria<\/a> as an absolute increase in serum creatinine of <strong>\u22650.3 mg\/dL<\/strong> within 48 hours, a relative increase of <strong>\u22651.5 times baseline<\/strong> within 7 days, or a urine output of <strong>&lt;0.5 mL\/kg\/h<\/strong> for at least 6 hours.  Diagnosis of CI-AKI following intravascular contrast exposure needs exclusion of alternative etiology.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It remains one of the most common causes of iatrogenic renal failure, particularly following percutaneous coronary interventions (PCI), and is independently associated with prolonged hospital stays, increased short-term mortality, and a higher risk of subsequent myocardial infarction and target lesion revascularization.<sup><\/sup><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The exact mechanism is multifactorial, but it fundamentally hinges on an imbalance between renal oxygen supply and demand, compounded by direct cellular toxicity:<sup><\/sup><\/p>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li class=\"\"><strong>Medullary Ischemia:<\/strong> The renal medulla operates on the brink of hypoxia even under normal conditions. Contrast media increases blood viscosity and alters renal hemodynamics, leading to intense, prolonged vasoconstriction of the vasa recta and subsequent medullary hypoxia.<\/li>\n\n\n\n<li class=\"\"><strong>Direct Tubular Toxicity:<\/strong> Contrast agents exert a direct cytotoxic effect on the renal proximal tubular cells. The hyperosmolality of the contrast draws fluid into the tubules, increasing intratubular pressure and decreasing the glomerular filtration gradient.<\/li>\n\n\n\n<li class=\"\"><strong>Oxidative Stress:<\/strong> The ischemic environment generates reactive oxygen species (ROS), which further exacerbate endothelial dysfunction and tubular damage.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\">Risk Stratification<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The most critical step before angiography is identifying vulnerable patients. Pre-existing chronic kidney disease (CKD) is the single most powerful predictor.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Fixed Risk Factors<\/strong><\/td><td><strong>Modifiable\/Peri-Procedural Risk Factors<\/strong><\/td><\/tr><\/thead><tbody><tr><td>Pre-existing CKD (eGFR &lt; 60 mL\/min\/1.73m\u00b2)<\/td><td>High contrast volume (&gt;100 mL)<\/td><\/tr><tr><td>Diabetes Mellitus<\/td><td>Hypotension or Hemodynamic instability<\/td><\/tr><tr><td>Advanced Age (&gt;75 years)<\/td><td>Nephrotoxic drugs (NSAIDs, etc.)<\/td><\/tr><tr><td>Congestive Heart Failure (NYHA III\/IV)<\/td><td>Anemia<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Routinely calculating the estimated Glomerular Filtration Rate (eGFR) is mandatory. The Mehran score is widely validated for PCI, assigning points for parameters like hypotension, IABP use, CHF, age, anemia, diabetes, contrast volume, and baseline eGFR to predict the risk of CI-AKI and the potential need for dialysis.<sup><\/sup><\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\"><strong>Clinical Note:<\/strong> Metformin does <em>not<\/em> cause CI-AKI, but it is typically held 24 hours before and 48 hours after procedures in patients with eGFR &lt; 60. This is done to prevent lactic acidosis in the event that CI-AKI does occur and the drug accumulates.<\/p>\n<\/blockquote>\n\n\n\n<h2 class=\"wp-block-heading\">Cath Lab Prevention Strategies<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Once a high-risk patient is identified, procedural strategy shifts heavily toward contrast conservation and optimal hemodynamics.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">1. Tailored Hydration<sup><\/sup><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Intravenous hydration with <strong>isotonic saline (0.9% NaCl)<\/strong> remains the cornerstone of prevention. While standard fixed-rate protocols are common, recent evidence favors <strong>tailored hydration<\/strong>. Adjusting the fluid infusion rate based on objective measurements of volume status\u2014such as Left Ventricular End-Diastolic Pressure (LVEDP) or Urine Flow Rate (UFR)\u2014outperforms standard regimens in preventing CI-AKI without significantly increasing the risk of pulmonary edema.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">2. Contrast Sparing and Selection<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Volume Limits:<\/strong> The total contrast volume should be strictly minimized. A universally accepted threshold is maintaining a <strong>Contrast Volume to eGFR ratio of &lt; 3.7<\/strong>.<\/li>\n\n\n\n<li class=\"\"><strong>Contrast Type:<\/strong> Low-osmolar (LOCM) or iso-osmolar contrast media (IOCM) are recommended over high-osmolar agents.<\/li>\n\n\n\n<li class=\"\"><strong>Diversion Systems:<\/strong> Devices like the DyeVert system can self-adjust to injection pressure, diverting excess contrast into a reservoir rather than the systemic circulation, often achieving a <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35547222\/\" type=\"link\" id=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35547222\/\">~40% reduction in contrast volume<\/a> without compromising image quality.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The <strong><a href=\"https:\/\/punchthrough.com\/portfolio\/osprey-medical-dyevert-plus\/\" type=\"link\" id=\"https:\/\/punchthrough.com\/portfolio\/osprey-medical-dyevert-plus\/\">DyeVert\u2122 Contrast Reduction System<\/a><\/strong> (developed by Osprey Medical) is a dedicated contrast-sparing technology utilized in the cath lab to minimize the risk of Contrast-Induced Acute Kidney Injury (CI-AKI), particularly in vulnerable patients undergoing diagnostic angiography or percutaneous coronary intervention (PCI).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Its primary function is to reduce the total volume of contrast delivered to the patient without compromising the fluoroscopic image quality required for the procedure.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Mechanism of Action<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">During standard manual injection, physicians typically deliver a volume and pressure of contrast that exceeds what is actually necessary to opacify the target vessel. This &#8220;excess&#8221; contrast flows back into the aorta and systemic circulation, increasing the renal burden without adding diagnostic value.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The DyeVert system addresses this fluid dynamic inefficiency:<\/p>\n\n\n\n<ol start=\"1\" class=\"wp-block-list\">\n<li class=\"\"><strong>Pressure Modulation:<\/strong> The device is installed in-line between the standard manifold and the diagnostic or guide catheter.<\/li>\n\n\n\n<li class=\"\"><strong>Active Diversion:<\/strong> As the physician performs a manual injection, the system&#8217;s proprietary valves sense the injection pressure. It dynamically self-adjusts to fluid resistance and diverts the excess, non-diagnostic contrast into a secondary reservoir bag before it ever enters the catheter.<\/li>\n\n\n\n<li class=\"\"><strong>Maintained Opacification:<\/strong> Only the contrast volume necessary to achieve optimal coronary opacification is allowed to proceed into the patient.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\">Clinical Utility in the Cath Lab<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Volume Reduction:<\/strong> Clinical studies and registry data typically show that the DyeVert system reduces total contrast volume by <strong>30% to 40%<\/strong> per procedure compared to standard manual injection.<\/li>\n\n\n\n<li class=\"\"><strong>Real-time Monitoring:<\/strong> The system includes a wireless, digital display that tracks the cumulative contrast dose in real-time. The operator can input the patient&#8217;s baseline eGFR to establish a maximum contrast threshold (e.g., a Contrast Volume\/eGFR ratio of &lt; 3.7). The display alerts the team as the patient approaches this limit.<\/li>\n\n\n\n<li class=\"\"><strong>Target Population:<\/strong> It is most frequently deployed during complex, multi-vessel PCI or Chronic Total Occlusion (CTO) interventions where prolonged imaging is required, specifically for patients with pre-existing CKD, diabetes, or advanced age.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">System Variations<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">There are a few iterations of the technology, such as the <strong>DyeVert Plus<\/strong> and <strong>DyeVert Plus EZ<\/strong>, which streamline the setup process for the cath lab staff, integrating more seamlessly with standard manifolds and automatic contrast injectors.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">By actively mitigating the volume of contrast administered, it serves as a critical mechanical adjunct to the pharmacological and hydration protocols used for high-risk renal patients.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">3. Procedural Techniques<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Radial Access:<\/strong> As demonstrated in the <a href=\"https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2017.02.070\" type=\"link\" id=\"https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2017.02.070\">AKI-MATRIX trial<\/a>, radial access is associated with significantly less AKI compared to femoral access. This is largely attributed to reduced bleeding (and thereby less hemodynamic instability) and a lower risk of catheter-induced atheroembolism to the renal microvasculature from descending aorta manipulation.<\/li>\n\n\n\n<li class=\"\"><strong>Biplane vs. Monoplane:<\/strong> While biplane angiography can theoretically reduce contrast use, it drastically increases radiation dose. Monoplane fluoroscopy with careful test injections and software roadmapping remains the default approach.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">4. Pharmacologic Adjuncts<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Pre-treatment with high-dose statins (e.g., Atorvastatin 80mg or Rosuvastatin 40mg) in statin-na\u00efve patients is recommended. Statins likely confer protection through their pleiotropic anti-inflammatory properties and improvement of endothelial function, independent of lipid lowering. Trials involving N-acetylcysteine (NAC) and sodium bicarbonate (like the <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29130810\/\" type=\"link\" id=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29130810\/\">PRESERVE trial<\/a>) have largely failed to show consistent benefit over standard saline hydration.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Contrast-Induced Acute Kidney Injury (CI-AKI) is being increasingly referred to as Contrast-Associated Acute Kidney Injury (CA-AKI). That is because post-contrast AKI may have causes other than contrast exposure. AKI is classically defined by the KDIGO (Kidney Disease: Improving Global Outcomes) 2012 criteria as an absolute increase in serum creatinine of \u22650.3 mg\/dL within 48 hours, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":67280,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-67278","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Contrast-Associated Acute Kidney Injury - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Contrast-Associated Acute Kidney Injury - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Contrast-Induced Acute Kidney Injury (CI-AKI) is being increasingly referred to as Contrast-Associated Acute Kidney Injury (CA-AKI). That is because post-contrast AKI may have causes other than contrast exposure. AKI is classically defined by the KDIGO (Kidney Disease: Improving Global Outcomes) 2012 criteria as an absolute increase in serum creatinine of \u22650.3 mg\/dL within 48 hours, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-04T04:06:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-04T04:06:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Contrast-Associated-Acute-Kidney-Injury.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1201\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Contrast-Associated Acute Kidney Injury\",\"datePublished\":\"2026-06-04T04:06:03+00:00\",\"dateModified\":\"2026-06-04T04:06:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/\"},\"wordCount\":1069,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Contrast-Associated-Acute-Kidney-Injury.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/\",\"name\":\"Contrast-Associated Acute Kidney Injury - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Contrast-Associated-Acute-Kidney-Injury.jpg\",\"datePublished\":\"2026-06-04T04:06:03+00:00\",\"dateModified\":\"2026-06-04T04:06:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Contrast-Associated-Acute-Kidney-Injury.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Contrast-Associated-Acute-Kidney-Injury.jpg\",\"width\":1201,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/contrast-associated-acute-kidney-injury\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Contrast-Associated Acute Kidney Injury\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Contrast-Associated Acute Kidney Injury - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/","og_locale":"en_US","og_type":"article","og_title":"Contrast-Associated Acute Kidney Injury - All About Cardiovascular System and Disorders","og_description":"Contrast-Induced Acute Kidney Injury (CI-AKI) is being increasingly referred to as Contrast-Associated Acute Kidney Injury (CA-AKI). That is because post-contrast AKI may have causes other than contrast exposure. AKI is classically defined by the KDIGO (Kidney Disease: Improving Global Outcomes) 2012 criteria as an absolute increase in serum creatinine of \u22650.3 mg\/dL within 48 hours, [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-06-04T04:06:03+00:00","article_modified_time":"2026-06-04T04:06:05+00:00","og_image":[{"width":1201,"height":675,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Contrast-Associated-Acute-Kidney-Injury.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Contrast-Associated Acute Kidney Injury","datePublished":"2026-06-04T04:06:03+00:00","dateModified":"2026-06-04T04:06:05+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/"},"wordCount":1069,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Contrast-Associated-Acute-Kidney-Injury.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/","url":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/","name":"Contrast-Associated Acute Kidney Injury - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Contrast-Associated-Acute-Kidney-Injury.jpg","datePublished":"2026-06-04T04:06:03+00:00","dateModified":"2026-06-04T04:06:05+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Contrast-Associated-Acute-Kidney-Injury.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/06\/Contrast-Associated-Acute-Kidney-Injury.jpg","width":1201,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/contrast-associated-acute-kidney-injury\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Contrast-Associated Acute Kidney Injury"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67278","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=67278"}],"version-history":[{"count":5,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67278\/revisions"}],"predecessor-version":[{"id":67288,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67278\/revisions\/67288"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/67280"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=67278"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=67278"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=67278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}